TS
Truist Securities Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
626
Coterra Energy
CTRA
$18.6B
|
ND
Neal Dingmann
| $24.37 | $37 |
52%
upside
| Buy |
13 Jan ‘25
8 months ago |
|
627
ConocoPhillips
COP
$118B
|
ND
Neal Dingmann
| $94.32 | $139 |
47%
upside
| Buy |
13 Jan ‘25
8 months ago |
|
628
Comstock Resources
CRK
$4.65B
|
ND
Neal Dingmann
| $15.85 | $19 |
20%
upside
| Hold |
13 Jan ‘25
8 months ago |
|
629
Antero Resources
AR
$10.1B
|
ND
Neal Dingmann
| $32.85 | $38 |
16%
upside
| Hold |
13 Jan ‘25
8 months ago |
|
630
Chord Energy
CHRD
$6.1B
|
ND
Neal Dingmann
| $106.55 | $186 |
75%
upside
| Buy |
13 Jan ‘25
8 months ago |
|
631
Northern Oil and Gas
NOG
$2.52B
|
ND
Neal Dingmann
| $25.78 | $55 |
113%
upside
| Buy |
13 Jan ‘25
8 months ago |
|
632
California Resources
CRC
$4.42B
|
ND
Neal Dingmann
| $52.82 | $75 |
42%
upside
| Buy |
13 Jan ‘25
8 months ago |
|
|
VRNA
633
Verona Pharma
VRNA
$9.2B
|
JL
Joon Lee
| $106.37 | $57 |
46%
downside
| Buy |
8 Jan ‘25
8 months ago |
|
634
Summit Therapeutics
SMMT
$13.1B
|
AG
Asthika Goonewardene
| $17.61 | $35 |
99%
upside
| Buy |
8 Jan ‘25
8 months ago |
|
635
Solid Biosciences
SLDB
$408M
|
JL
Joon Lee
| $5.24 | $16 |
205%
upside
| Buy |
8 Jan ‘25
8 months ago |
|
636
Amgen
AMGN
$150B
|
RK
Robyn Karnauskas
| $278.51 | $298 |
7%
upside
| Hold |
8 Jan ‘25
8 months ago |
|
637
Bristol-Myers Squibb
BMY
$96B
|
RK
Robyn Karnauskas
| $47.15 | $65 |
38%
upside
| Buy |
8 Jan ‘25
8 months ago |
|
638
Merck
MRK
$210B
|
RK
Robyn Karnauskas
| $84.03 | $110 |
31%
upside
| Hold |
8 Jan ‘25
8 months ago |
|
639
Citigroup
C
$179B
| $97.17 | $85 |
13%
downside
| Buy |
7 Jan ‘25
8 months ago |
|
|
640
PACS Group
PACS
$1.2B
|
DM
David Macdonald
| $7.71 | $32 |
315%
upside
| Buy |
6 Jan ‘25
8 months ago |
|
|
DEC
641
Diversified Energy
DEC
$1.22B
|
BD
Bertrand Donnes
| $15.74 | $27 |
72%
upside
| Buy |
6 Jan ‘25
8 months ago |
|
|
ARDT
642
Ardent Health, Inc.
ARDT
$1.86B
|
DM
David Macdonald
| $13.03 | $21 |
61%
upside
| Buy |
6 Jan ‘25
8 months ago |
|
643
Enterprise Products Partners
EPD
$68.5B
|
ND
Neal Dingmann
| $31.65 | $40 |
26%
upside
| Buy |
3 Jan ‘25
8 months ago |
|
644
Medical Properties Trust
MPW
$2.77B
|
ML
Michael Lewis
| $4.61 | $4 |
13%
downside
| Hold |
19 Dec ‘24
8 months ago |
|
645
AnaptysBio
ANAB
$637M
|
JL
John Lee
| $22.78 | $20 |
12%
downside
| Hold |
18 Dec ‘24
8 months ago |
|
646
Vericel Corp
VCEL
$1.58B
|
SB
Samuel Brodovsky
| $31.31 | $67 |
114%
upside
| Buy |
18 Dec ‘24
8 months ago |
|
647
Pfizer
PFE
$140B
|
SD
Srikripa Devarakonda
| $24.57 | $32 |
30%
upside
| Buy |
18 Dec ‘24
8 months ago |
|
648
Penumbra
PEN
$10.6B
|
RN
Richard Newitter
| $271.98 | $285 |
5%
upside
| Buy |
18 Dec ‘24
8 months ago |
|
649
FIVE9
FIVN
$1.95B
|
TT
Terry Tillman
| $25.28 | $65 |
157%
upside
| Buy |
17 Dec ‘24
8 months ago |
|
650
HCI Group
HCI
$2.31B
|
MH
Mark Hughes
| $178.12 | $145 |
19%
downside
| Buy |
17 Dec ‘24
8 months ago |
|